Standardization of immunoassays for measurement of myoglobin in serum. Phase I: Evaluation of candidate secondary reference materials

Clinica Chimica Acta

Volumn 341, Issue 1-2, 2004, Pages 65-72

  Panteghini, Mauro ^a   Linsinger, Thomas ^b   Wu, Alan H B ^c   Dati, Francesco ^d   Apple, Fred S ^e   Christenson, Robert H ^f   Mair, Johannes ^g   Schimmel, Heinz ^b  

^a SPEDALI CIVILI   (Italy)

^b JOINT RESEARCH CENTRE   (Italy)

^c HARTFORD HOSPITAL   (United States)

^d IVD Consulting   (Germany)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Commutability; Myoglobin; Reference materials; Standardization

Indexed keywords

FRESH FROZEN PLASMA; MYOGLOBIN;

ACCURACY; ARTICLE; AUTOANALYSIS; BLOOD ANALYSIS; CALIBRATOR; CATTLE; HUMAN; IMMUNOASSAY; MATERIALS TESTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STANDARDIZATION;

EID: 1142297462     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.030     Document Type: Article

References (21)

1. Panteghini M., Pagani F., Bonetti G. The sensitivity of cardiac markers: an evidence-based approach. Clin. Chem. Lab. Med. 37:1999;1097-1106.
2. Stone M.J., Willerson J.T., Gomez-Sanchez C.E., Waterman M.R. Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction. J. Clin. Invest. 56:1975;134-139.
3. Wu A.H.B., Laios I., Green S., Gornet T.G., Wong S.S., Parmaley L.et al. Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin. Chem. 40:1994;796-802.
4. Wu A.H.B., Apple F.S., Gibler W.B., Jesse R.L., Warshaw M.M., Valdes R. Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for use of cardiac markers in coronary artery diseases. Clin. Chem. 45:1999;1104-1121.
5. Panteghini M., Apple F.S., Christenson R.H., Dati F., Mair J., Wu A.H. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry. Clin. Chem. Lab. Med. 37:1999;687-693.
6. Fesmire F.M., Campbell M., Decker W.W., Howell J.M., Kline J.A. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. Ann. Emerg. Med. 35:2000;521-544.
7. Christenson R.H., Vaidya H., Landt Y., Bauer R.S., Green S.F., Apple F.A.et al. Standardization of creatine kinase-MB (CK-MB) mass assays: the use of recombinant CK-MB as a reference material. Clin. Chem. 45:1999;1414-1423.
8. Christenson R.H., Apple F., Bodor G., Bunk D., Dalluge J., Duh S.H.et al. Standardization of cardiac troponin I assays: round robin of ten candidate reference materials. Clin. Chem. 47:2001;431-437.
9. College of American Pathologist Cardiac Markers Survey, Northfield, IL: 2003.
10. Panteghini M. Recent approaches to the standardization of cardiac markers. Scand. J. Clin. Lab. Invest. 61:2001;95-102.
11. Miller W.G. Specimen materials, target values and commutability for external quality assessment (proficiency testing) schemes. Clin. Chim. Acta. 327:2003;25-37.
12. Zaninotto M., Pagani F., Altinier S., Amboni P., Bonora R., Dolci A.et al. Multicenter evaluation of five assays for myoglobin determination. Clin. Chem. 46:2000;1631-1637.
13. Le Moigne F., Beauvieux M.C., Derache P., Darmon Y.M. Determination of myoglobin: comparative evaluation of the new automated VIDAS assay with two other immunoassays. Clin. Biochem. 35:2002;255-262.
14. Panteghini M. Standardization of cardiac markers. Wu A.H.B. Cardiac Markers. 2nd ed. 2003;213-229 Humana Press, Totowa, NJ.
15. Dati F., Panteghini M., Apple F.S., Christenson R.H., Mair J., Wu A.H. Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays. Scand. J. Clin. Lab. Invest. 230:1999;113-123. [suppl].
16. Dati F., Linsinger T., Apple F.S., Christenson R.H., Mair J., Ravkilde J.et al. IFCC project for standardization of myoglobin immunoassays. Clin. Chem. Lab. Med. 40:2002;S311.
17. Jesse R.L. Rationale for the early clinical application of markers of ischemia in patients with suspected acute coronary syndromes. Wu A.H.B. Cardiac Markers. 2nd ed. 2003;245-257 Humana Press, Totowa, NJ.
18. Wu A.H.B., Feng Y.J., Moore R., Apple F.S., McPherson P., Buechler K.et al. Characterization of cardiac troponin subumit release into serum following acute myocardial infarction, and comparison of assays for troponin T and I. Clin. Chem. 44:1998;1198-1208.
19. Labugger R., Organ L., Collier C., Atar D., Van Eyk J.E. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation. 102:2000;1221-1226.
20. Vaidya H.C., Maynard Y., Dietzler D.N., Ladenson J.H. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin. Chem. 32:1986;657-663.
21. Müller M.M. Implementation of reference systems in laboratory medicine. Clin. Chem. 46:2000;1907-1909.